“Tiotropium bromide in the routine care of GOLD stage II COPD patients: a pharmaeconomic evaluation” (2011) Farmeconomia. Health economics and therapeutic pathways, 12(2), pp. 45–52. doi:10.7175/fe.v12i2.70.